Scott L. Zeger

75.5k total citations · 16 hit papers
344 papers, 55.9k citations indexed

About

Scott L. Zeger is a scholar working on Statistics and Probability, Health, Toxicology and Mutagenesis and General Health Professions. According to data from OpenAlex, Scott L. Zeger has authored 344 papers receiving a total of 55.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Statistics and Probability, 53 papers in Health, Toxicology and Mutagenesis and 45 papers in General Health Professions. Recurrent topics in Scott L. Zeger's work include Air Quality and Health Impacts (49 papers), Statistical Methods and Bayesian Inference (47 papers) and Statistical Methods and Inference (31 papers). Scott L. Zeger is often cited by papers focused on Air Quality and Health Impacts (49 papers), Statistical Methods and Bayesian Inference (47 papers) and Statistical Methods and Inference (31 papers). Scott L. Zeger collaborates with scholars based in United States, United Kingdom and Nepal. Scott L. Zeger's co-authors include Kung‐Yee Liang, Kung‐Yee Liang, Peter J. Diggle, Francesca Dominici, Paul S. Albert, Jonathan M. Samet, Patrick J. Heagerty, Roger D. Peng, Jonathan M. Samet and Michelle L. Bell and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Scott L. Zeger

326 papers receiving 53.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longitudinal data analysis using generalized linear models

1986 14.4k citations Scott L. Zeger et al. profile →
Longitudinal Data Analysis for Discrete and Continuous Outcomes

1986 6.6k citations Scott L. Zeger et al. Biometrics profile →
Models for Longitudinal Data: A Generalized Estimating Equation Approach

1988 3.6k citations Scott L. Zeger et al. Biometrics profile →
Analysis of Longitudinal Data

2002 2.5k citations Scott L. Zeger et al. profile →
Fine Particulate Air Pollution and Hospital Admission for Cardiovascular and Respiratory Diseases

2006 2.1k citations Scott L. Zeger et al. profile →
Fine Particulate Air Pollution and Mortality in 20 U.S. Cities, 1987–1994

2000 1.8k citations Scott L. Zeger et al. profile →
Exposure measurement error in time-series studies of air pollution: concepts and consequences.

2000 972 citations Scott L. Zeger et al. profile →
Analysis of Longitudinal Data.

1995 956 citations Scott L. Zeger et al. profile →
Phenotype of Frailty: Characterization in the Women's Health and Aging Studies

2006 931 citations Karen Bandeen‐Roche, Scott L. Zeger et al. profile →
Longitudinal Data Analysis Using Generalized Linear Models

1986 745 citations Scott L. Zeger et al. profile →
Generalized Linear Models with Random Effects; a Gibbs Sampling Approach

1991 658 citations Scott L. Zeger et al. profile →
Regression Analysis for Correlated Data

1993 654 citations Scott L. Zeger et al. profile →
The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States.

2000 560 citations Scott L. Zeger et al. profile →
Spatial and Temporal Variation in PM _2.5 Chemical Composition in the United States for Health Effects Studies

2007 557 citations Francesca Dominici, Scott L. Zeger et al. profile →
Multivariate Regression Analyses for Categorical Data

1992 551 citations Scott L. Zeger et al. profile →
An overview of methods for the analysis of longitudinal data

1992 504 citations Scott L. Zeger et al. profile →

Peers

Countries citing papers authored by Scott L. Zeger

Since Specialization

Citations

This map shows the geographic impact of Scott L. Zeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Zeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Zeger more than expected).

Fields of papers citing papers by Scott L. Zeger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Zeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Zeger. The network helps show where Scott L. Zeger may publish in the future.

Co-authorship network of co-authors of Scott L. Zeger

This figure shows the co-authorship network connecting the top 25 collaborators of Scott L. Zeger. A scholar is included among the top collaborators of Scott L. Zeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott L. Zeger. Scott L. Zeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Light Physical Activity and All‐Cause Mortality in US Adults Across Cardiovascular‐Kidney‐Metabolic Syndrome Stages 2026 ·Journal of the American Heart Association ·(unknown), (unknown), (unknown), John W. McEvoy, Chiadi E. Ndumele, Scott L. Zeger, (unknown), Michael Fang	1
2	Two clinical subgroups of immune checkpoint inhibitor-induced inflammatory arthritis determined by latent class analysis 2025 ·Seminars in Arthritis and Rheumatism ·Laura C. Cappelli, Jamie Perin, Scott L. Zeger, (unknown), Clifton O. Bingham, Ami A. Shah	1
3	Social Risk Groups in Patients With Diabetes With Differing Eye Care Utilization and Vision Outcomes 2024 ·Translational Vision Science & Technology ·Cindy X. Cai, Dingfen Han, Diep Tran, (unknown), Scott L. Zeger, Deidra C. Crews	0
4	The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD 2024 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Richard C. Mohs, (unknown), Sharon Rosenzweig‐Lipson, Michael Rosenblum, (unknown), Marilyn S. Albert, Sharon Cohen, Scott L. Zeger, Michela Gallagher	15
5	Place, Race, and Lapses in Diabetic Retinopathy Care 2024 ·JAMA Ophthalmology ·Tina Tang, Diep Tran, Dingfen Han, Scott L. Zeger, Deidra C. Crews, Cindy X. Cai	5
6	Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission 2023 ·Blood ·(unknown), Georgia Andrew, Gege Gui, (unknown), Devdeep Mukherjee, Zoë C. Wong, Jeffery J. Auletta, Firas El Chaer, Adam Corner, Steven M. Devine, Antonio Jiménez, Marcos de Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Stephen R. Spellman, Scott L. Zeger, Kristin Page, Laura W. Dillon, Christopher S. Hourigan	1
7	Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome 2022 ·Clinical Infectious Diseases ·Matthew L. Robinson, C. Paul Morris, Joshua Betz, Yifan Zhang, Robert C. Bollinger, (unknown), David R. Thiemann, (unknown), Raghda E. Eldesouki, Julie M. Norton, David C. Gaston, Michael Forman, Chun Huai Luo, Scott L. Zeger, Amita Gupta, Brian T. Garibaldi, Heba H. Mostafa	17
8	Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis 2022 ·Lara D. Veeken ·Carrie Richardson, Jamie Perin, Scott L. Zeger, Fredrick M. Wigley, Laura K. Hummers, Livia Casciola‐Rosen, Antony Rosen, Ami A. Shah	7
9	Development of an imputation model to recalibrate birth weights measured in the early neonatal period to time at delivery and assessment of its impact on size-for-gestational age and low birthweight prevalence estimates: a secondary analysis of a pregnancy cohort in rural Nepal 2022 ·BMJ Open ·Elizabeth Hazel, Luke C. Mullany, Scott L. Zeger, Diwakar Mohan, (unknown), James M. Tielsch, Subarna K. Khatry, Joanne Katz	2
10	Prevalence and predictors of spontaneous preterm births in Nepal: findings from a prospective, population-based pregnancy cohort in rural Nepal–a secondary data analysis 2022 ·BMJ Open ·(unknown), Elizabeth Hazel, Diwakar Mohan, Scott L. Zeger, Luke C. Mullany, James M. Tielsch, Subarna K. Khatry, Steven C. LeClerq, Robert E. Black, Joanne Katz	5
11	Sex and Gender Differences in Testing, Hospital Admission, Clinical Presentation, and Drivers of Severe Outcomes From COVID-19 2021 ·Open Forum Infectious Diseases ·Eileen P. Scully, (unknown), (unknown), Guido Massaccesi, John Muschelli, Joshua Betz, Eili Klein, Natalie E. West, Matthew L. Robinson, Brian T. Garibaldi, Karen Bandeen‐Roche, Scott L. Zeger, Sabra L. Klein, Amita Gupta	39
12	A Bayesian approach to restricted latent class models for scientifically structured clustering of multivariate binary outcomes 2020 ·Biometrics ·Zhenke Wu, Livia Casciola‐Rosen, Antony Rosen, Scott L. Zeger	4
13	Pilot Assessment of the BMET Decision Support Platform: A Tool to Improve Provider Survival Estimates and Selection of Prognosis-Appropriate Treatment for Patients with Symptomatic Bone Metastases 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Sara R. Alcorn, Jacob Fiksel, Chen Hu, Jean L. Wright, Lawrence Kleinberg, Adam S. Levin, Thomas J. Smith, (unknown), (unknown), Kenneth Kim, A.D. Rao, Lindsey Sloan, B.R. Page, Susan Stinson, (unknown), (unknown), Michael R. Bowers, Theodore L. DeWeese, Scott L. Zeger	5
14	Development of summary indices of antenatal care service quality in Haiti, Malawi and Tanzania 2019 ·BMJ Open ·Ashley Sheffel, Scott L. Zeger, Rebecca Heidkamp, Melinda Munos	19
15	Estimating autoantibody signatures to detect autoimmune disease patient subsets 2017 ·Biostatistics ·Zhenke Wu, Livia Casciola‐Rosen, Ami A. Shah, Antony Rosen, Scott L. Zeger	2
16	It's no longer a pipeline problem, so what are the root causes? 2009 ·ACADEME University of Bohol Graduate School and Professional Studies ·(unknown), Linda P. Fried, Scott L. Zeger	4
17	So Few Women Leaders. 2009 ·ACADEME University of Bohol Graduate School and Professional Studies ·Francesca Dominici, Linda P. Fried, Scott L. Zeger	22
18	Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials 2001 ·Controlled Clinical Trials ·(unknown), Pamela Clax, David L. DeMets, Gregory J. Downing, Susan S. Ellenberg, Lawrence S. Friedman, Mitchell H. Gail, Ross L. Prentice, Janet Wittes, Scott L. Zeger	286
19	Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection 1990 ·AIDS Research and Human Retroviruses ·Leigh A. Sawyer, David Katzenstein, R. Michael Hendry, E Boone, Luba K. Vujcic, (unknown), Scott L. Zeger, Alfred J. Saah, Charles R. Rinaldo, John Phair, (unknown), Gerald V. Quinnan	66
20	STATISTICAL ANALYSIS OF UMKEHR MEASUREMENTS OF 32-46 km OZONE. 1982 ·Journal of Applied Meteorology ·Peter Bloomfield, Mary Lou Thompson, Scott L. Zeger	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact